Auteurs Loubiere C, Clavel S, Gilleron J, Harisseh R, Fauconnier J, Ben-Sahra I, Kaminski L, Laurent K, Herkenne S, Lacas-Gervais S, Ambrosetti D, Alcor D, Rocchi S, Cormont M, Michiels JF, Mari B, Mazure NM, Scorrano L, Lacampagne A, Gharib A, Tanti JF, Bost F
Scientific reports Juil 2017
Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma.Auteurs Benadiba J, Rosilio C, Nebout M, Heimeroth V, Neffati Z, Popa A, Mary D, Griessinger E, Imbert V, Sirvent N, Peyron JF
Leukemia & lymphoma Juin 2017
Neonatal expression of RNA-binding protein IGF2BP3 regulates the human fetal-adult megakaryocyte transition.Auteurs Elagib KE, Lu CH, Mosoyan G, Khalil S, Zasadzińska E, Foltz DR, Balogh P, Gru AA, Fuchs DA, Rimsza LM, Verhoeyen E, Sansó M, Fisher RP, Iancu-Rubin C, Goldfarb AN
The Journal of clinical investigation Jun 2017
High SYK Expression Drives Constitutive Activation of CD21 B Cells.Auteurs Keller B, Stumpf I, Strohmeier V, Usadel S, Verhoeyen E, Eibel H, Warnatz K
Journal of immunology (Baltimore, Md. : 1950) Juin 2017
Ezrin enhances line tension along transcellular tunnel edges via NMIIa driven actomyosin cable formation.Auteurs Stefani C, Gonzalez-Rodriguez D, Senju Y, Doye A, Efimova N, Janel S, Lipuma J, Tsai MC, Hamaoui D, Maddugoda MP, Cochet-Escartin O, Prévost C, Lafont F, Svitkina T, Lappalainen P, Bassereau P, Lemichez E
Nature communications Juin 2017
Focus on cutaneous and uveal melanoma specificities.Auteurs Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C
Genes & development May 2017
Focus on cutaneous and uveal melanoma specificities.Auteurs Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C
Genes & development May 2017
Focus on cutaneous and uveal melanoma specificities.Auteurs Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C
Genes & development May 2017
Focus on cutaneous and uveal melanoma specificities.Auteurs Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C
Genes & development May 2017
Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.Auteurs Olvedy M, Tisserand JC, Luciani F, Boeckx B, Wouters J, Lopez S, Rambow F, Aibar S, Thienpont B, Barra J, Köhler C, Radaelli E, Tartare-Deckert S, Aerts S, Dubreuil P, van den Oord JJ, Lambrechts D, De Sepulveda P, Marine JC
The Journal of clinical investigation May 2017